Clinical study · 2015
A prospective study of DT56a (Femarelle®) for the treatment of menopause symptoms
Climacteric
Researchers followed women experiencing hot flashes during everyday care and tracked their experiences.
Clinical study · 2004
Efficacy and safety of standard versus low-dose Femarelle (DT56a) for the treatment of menopausal symptoms
Clinical and Experimental Obstetrics & Gynecology
The study compared two amounts of DT56a in postmenopausal women over 12 months.
Clinical study · 2003
Tofupill/Femarelle (DT56a): a new phyto-selective estrogen receptor modulator-like substance for the treatment of postmenopausal bone loss
Menopause
This study measured bone density by DXA scans in postmenopausal women.
Clinical study · 2013
Efficacy and safety of DT56a compared to hormone therapy in Greek post-menopausal women
Journal of Endocrinological Investigation
Researchers compared symptom changes for women using DT56a, hormone therapy, or neither.
Clinical study · 2011
The selective estrogen receptor modulator DT56a (Femarelle) does not affect platelet reactivity in normal or thrombophilic postmenopausal women
Menopause
The study asked whether a laboratory measure of platelet function changed while women used DT56a.
Conference abstract · 2011
A Prospective Study of DT56a (Femarelle®) for the Treatment of Postmenopausal Vaginal Atrophy
NAMS Annual Congress presentation abstract
An early report examining intimate-health symptoms and vaginal tissue measures.
Conference abstract · citation only
Laboratory research · 2007
Pharmacological doses of the natural phyto-SERM DT56a (Femarelle) have no effect on MCF-7 human breast cancer cell-line
European Journal of Obstetrics & Gynecology and Reproductive Biology (letter)
Researchers examined how one estrogen-sensitive type of breast-cancer cell responded in a laboratory dish.
Animal research · 2011
The effects of native and synthetic estrogenic compounds as well as vitamin D less-calcemic analogs on adipocytes content in rat bone marrow
Journal of Endocrinological Investigation
The study explored biological changes in bone marrow after an experimentally induced estrogen decline.
Animal research · 2003
DT56a stimulates creatine kinase specific activity in vascular tissues of rats
Journal of Endocrinological Investigation
Researchers tested tissue-selective biological activity in blood-vessel and heart tissue.
Animal research · 2003
DT56a (Tofupill/Femarelle) selectively stimulates creatine kinase specific activity in skeletal tissues of rats but not in the uterus
Journal of Steroid Biochemistry & Molecular Biology
This experiment informed the proposed tissue-selective mechanism.
Laboratory research · 2006
DT56a stimulates gender-specific human cultured bone cells in vitro
Journal of Steroid Biochemistry & Molecular Biology
Osteoblasts are cells involved in building bone; this helps explore possible mechanisms.
Laboratory research · 2017
Interaction between the effects of the selective estrogen modulator femarelle and a vitamin D analog in human umbilical artery vascular smooth muscle cells
Journal of Steroid Biochemistry & Molecular Biology
Mechanistic laboratory research on vascular cell behavior.
Laboratory research · 2011
DT56a (Femarelle), contrary to estradiol-17β, is effective in human derived female osteoblasts in hyperglycemic condition
Journal of Steroid Biochemistry & Molecular Biology
The lab explored bone-cell responses under an artificial high-glucose environment.
Animal research · 2009
Brain-region responsiveness to DT56a (Femarelle) administration on allopregnanolone and opioid content in ovariectomized rats
Menopause
The study investigated biological pathways associated with stress, mood and brain signaling.
Animal research · 2005
Tofupill lacks peripheral estrogen-like actions in the rat reproductive tract
Reproductive Toxicology
This research assessed aspects of reproductive-tissue response in animals.
Preclinical research · 2007
DT56a (Femarelle): A natural selective estrogen receptor modulator (SERM)
Journal of Steroid Biochemistry & Molecular Biology
This study explores what 'selective' means at the cellular and tissue level.
Animal research · 2005
DT56a (Femarelle) stimulates bone formation in female rats
BJOG
Research tested bone architecture directly in an animal model of estrogen deficiency.